Insulin receptor signaling in the β-cell influences insulin gene expression and insulin content: Evidence for autocrine β-cell regulation

Diabetes

Volumn 47, Issue 8, 1998, Pages 1243-1252

  Xu, Gang G ^a   Rothenberg, Paul L ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR KINASE; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; INSULIN RELEASE; INSULIN SYNTHESIS; MOUSE; NONHUMAN; NORTHERN BLOTTING; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RADIOIMMUNOASSAY; RNA DEGRADATION; SIGNAL TRANSDUCTION; STEADY STATE; TRANSCRIPTION REGULATION;

ANIMALS; AUTOCRINE COMMUNICATION; CELL LINE; GENE EXPRESSION; INSULIN; ISLETS OF LANGERHANS; MICE; RECEPTOR, INSULIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 0031823491     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.8.1243     Document Type: Article

References (74)

1. White MF, Kahn CR: The insulin signaling system. J Biol Chem 269:1-4, 1994
2. Ashcroft FM, Ashcroft SJH: Insulin: Molecular Biology to Pathology. New York, Oxford University Press, 1992
3. Rosen OM: After insulin binds. Science 237:1452-1458, 1987
4. Kahn CR: The molecular mechanism of insulin action. Annu Rev Med 36:429-521, 1985
5. Becker AB, Roth RA: Insulin receptor structure and function in normal and pathological conditions. Annu Rev Med 41:99-115, 1990
6. Rothenberg PL, White M, Kahn CR: The insulin receptor tyrosine kinase. In The Handbook of Experimental Pharmacology. Berlin, Springer-Verlag, 1990, p. 209
7. Kasuga M, Zick Y, Blithe DL, Crettaz M, Kahn CR: Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system. Nature 298:667-669, 1982
8. Sun XJ, Rothenberg PL, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ, White MF: Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352:73-77, 1991
9. Myers MGJ, White MF: The new elements of insulin signaling: insulin receptor substrate-1 and proteins with SH2 domains. Diabetes 42:643-650, 1993
10. Rothenberg PL, Lane WS, Karasik A, Backer J, White MF, Kahn CR: Purification and partial sequence analysis of pp185, the major cellular substrate of the insulin receptor tyrosine kinase. J Biol Chem 266:8302-8311, 1991
11. Araki E, Sun XJ, Haag BL III, Chuang LM, Zhang Y, Yang-Fang TL, White MF, Kahn CR: Human skeletal muscle insulin receptor substrate-1: characterization of the cDNA, gene, and chromosomal localization. Diabetes 42:1041-1054, 1993
12. Nishiyama M, Wands JR: Cloning and increased expression of an insulin receptor substrate-1-like gene in human hepatocellular carcinoma, Biochem Biophys Res Commun 183:280-285, 1992
13. Keller SR, Aebersold R, Garner CW, Lienhard GE: The insulin-elicited 160 kDa phosphotyrosine protein in mouse adipocytes is an insulin receptor substrate 1: identification by cloning. Biochim Biophys Acta 1172:323-326, 1993
14. Sasaoka T, Draznin B, Leitner JW, Langlois WJ, Olefsky JM: Shc is the predominant signaling molecule coupling insulin receptors to activation of guanine nucleotide-releasing factor and p21ras-GTP formation. J Biol Chem 269:10734-10738, 1994
15. Kovacina KS, Roth RA: Identification of SHC as a substrate of the insulin receptor kinase distinct from the GAP-associated 62-kDa tyrosine phosphoprotein. Biochem Biophys Res Commun 192:1303-1311, 1993
16. Skolnik EY, Batzer A, Li N, Lee CH, Lowenstein E, Mohammadi M, Margolis B, Schlessinger J: The function of GRB2 in linking the insulin receptor to ras signaling pathways. Science 260:1953-1955, 1993
17. Skolnik EY, Lee CH, Batzer A, Vicentini LM, Zhou M, Daly R, Myers MJJ, Backer JM, Ullrich A, White MF, Schlessinger J: The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signaling. EMBO J 12:1929-1936, 1993
18. Pronk GJ, McGlade J, Pelicci G, Pawson T, Bos JL: Insulin-induced phosphorylation of the 46- and 52-kDa Shc proteins. J Biol Chem 268:5748-5753, 1993
19. Redmon JB, Towle HC, Robertson RP: Regulation of human insulin gene transcription by glucose, epinephrine, and somatostatin. Diabetes 43:546-551, 1994
20. Leahy JL, Vandekerkhove KM: Insulin-like growth factor-I at physiological concentrations is a potent inhibitor of insulin secretion. Endocrinology 126:1593-1598, 1990
21. Van Schravendijk CF, Heylen L, Van den Brande JL, Pipeleers DG: Direct effect of insulin and insulin-like growth factor-I on the secretory activity of rat pancreatic β-cells. Diabetologia 33:649-653, 1990
22. Ammon HPT, Verspohl E: Pyridine nucleotides in pancreatic islets during inhibition of insulin release by exogenous insulin. Endocrinology 99:1469-1476, 1976
23. Draznin B, Goodman M, Leitner JW, Sussman KE: Feedback inhibition of insulin on insulin secretion in isolated pancreatic islets. Endocrinology 118:1054-1058, 1986
24. Sodoyez J, Sodoyez-Goffaux F, Foa PP: Evidence for an insulin-induced inhibition of insulin release by isolated islets of Langerhans. Proc Soc Exp Biol Med 130:568-571, 1969
25. Loreti L, Dunbar JC, Foa PP: The autoregulation of insulin secretion in the isolated pancreatic islets of lean (ob/ob) and obese-hyperglycemic (pb/ob) mice. Diabetologia 10:309-315, 1974
26. Iversen J, Miles DW: Evidence for a feedback inhibition of insulin on insulin secretion in the isolated, perfused canine pancreas. Diabetes 20:1-9, 1971
27. Rappaport AM, Ohira S, Coddling JA, Empey G, Kalinins A, Lin BJ, Haist RE: Effects on insulin output and on pancreatic blood flow of exogenous insulin infusion into an in situ isolated portion of the pancreas. Endocrinology 91:168-176, 1972
28. Ammon HPT. Reiber C, Verspohl EJ: Indirect evidence for short-loop negative feedback of insulin secretion in the rat. J Endocrinol 128:27-34, 1991
29. Garvey WT, Revers RR, Kolterman OG, Olefsky JM: Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus. J Clin Endocrinol Metab 60:559-568, 1985
30. Liljenquist JE, Horwitz DL, Jennings AS, Chiasson J, Keller T, Rubenstein AH: Inhibition of insulin secretion by exogenous insulin in normal man as demonstrated by C-peptide assay. Diabetes 27:563-570. 1978
31. Blume N, Skouv J, Larsson L, Holst JJ, Madsen OD: Potent inhibitory effects of transplantable rat glucagonomas and insulinomas on the respective endogenous islet cells are associated with pancreatic apoptosis. J Clin Invest 96:2227-2235, 1995
32. Koranyi L, James DE, Kraegen EW, Permutt MA: Feedback inhibition of insulin gene expression by insulin. J Clin Invest 89:432-436, 1992
33. Zhang HJ, Petersen B, Robertson RP: Variable regulation by insulin of insulin gene expression in HIT-T15 cells. Diabetologia 37:559-566, 1994
34. Ashcroft SJH: Protein phosphorylation and β-cell function. Diabetologia 37 (Suppl. 2):S21-S29, 1994
35. Verspohl EJ, Tollkuhn B, Kloss H: Role of tyrosine kinase in insulin release in an insulin-secreting cell line (INS-1). Cell Signal 7:505-512, 1995
36. Sorenson RL, Brelje TC, Roth C: Effect of tyrosine kinase inhibitors on islets of Langerhans: evidence for tyrosine kinases in the regulation of insulin secretion. Endocrinology 134:1975-1978, 1994
37. Voss C, Herrmann I, Hartmann K, Zuhlke H: In vitro effect of vanadate on content, secretion, and biosynthesis of insulin in isolated islets of normal Wistar rats. Exp Clin Endocrinol 99:159-163, 1992
38. Harbeck MC, Louie DC, Howland J, Wolf BA, Rothenberg PL: Expression of insulin receptor mRNA and insulin receptor substrate 1 in pancreatic islet βcells. Diabetes 45:711-717, 1996
39. Rothenberg PL, Willison LD, Simon J, Wolf BA: Glucose-induced insulin receptor tyrosine phosphorylation in insulin-secreting β-cells. Diabetes 44:802-809, 1995
40. Okada T, Kawano Y, Sakakibara T, Hazeki O, Ui M: Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes: studies with a selective inhibitor wortmannin. J Biol Chem 269:3568-3573, 1994
41. Yano H, Nakanishi S, Kimura K, Hanai N, Saitoh Y, Fukui Y, Nonomura Y, Matsuda Y: Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J Biol Chem 268:25846-25856, 1993
42. Gao ZY, Konrad RJ, Collins H, Matschinsky FM, Rothenberg PL, Wolf BA: Wortmannin inhibits insulin secretion in pancreatic islets and β-TC3 cells independent of its inhibition of phosphatidylinositol 3-kinase. Diabetes 45:854-862, 1996
43. Alter CA, Wolf BA: Identification of phosphatidylinositol 3,4,5-trisphosphate in pancreatic islets and insulin-secreting β-cells. Biochem Biophys Res Commun 208:190-197, 1995
44. Knaack D, Fiore DM, Surana M, Leiser M, Laurance M, Fusco-DaMane D, Hegre OD, Fleischer N, Efrat S: Clonal insulinoma cell line that stably maintains correct glucose responsiveness. Diabetes 43:1413-1417, 1994
45. McClain DA, Maegawa H, Lee J, Dull TJ, Ulrich A, Olefsky JM: A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis. J Biol Chem 262:14663-14671, 1987
46. Prigent SA, Stanley KK, Siddle K: Identification of epitopes on the human insulin receptor reacting with rabbit polyclonal antisera and mouse monoclonal antibodies. J Biol Chem 265:9970-9977, 1990
47. Ganderton RH, Stanley KK, Field CE, Coghlan MP, Soos MA, Siddle K: A monoclonal anti-peptide antibody reacting with the insulin receptor β-subunit characterization of the antibody and its epitope and use in immunoaffinity purification of intact receptors. Biochem J 288:195-205, 1992
48. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970
49. Brunk CF, Jones KC, James TW: Assay for nanogram quantities of DNA in cellular homogenates. Anal Biochem 92:497-500, 1979
50. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
51. Cleveland DW, Lopata MA, MacDonald RJ, Cowan NJ, Rutter WJ, Kirschner MW: Number and evolutionary conservation of α- and β-tubulin and cytoplasmic β- and γ-actin genes using specific cloned cDNA probes. Cell 20:95-105, 1980
52. Welsh M, Nielsen DA, MacKrell AJ, Steiner DF: Control of insulin gene expression m pancreatic β-cells and in an insulin-producing cell line, RIN-5F cells. II. Regulation of insulin mRNA stability. J Biol Chem 260:13590-13594, 1985
53. Schuit FC, In't Veld PA, Pipeleers DG: Glucose stimulates proinsulin biosynthesis by a dose-dependent recruitment of pancreatic β-cells. Proc Natl Acad Sci U S A 85:3865-3869, 1988
54. Chang PY, Benecke H, Le Marchand-Brustel Y, Lawitts J, Moller DE: Expression of a dominant-negative mutant human insulin receptor in the muscle of transgenic mice. J Biol Chem 269:16034-16040, 1994
55. Giorgino F, Belfiore A, Milazzo G, Costantino A, Maddux B, Whittaker J, Goldfine ID, Vigneri R: Overexpression of insulin receptors in fibroblast and ovary cells induces a ligand-mediated transformed phenotype. Mol Endocrinol 5:452-459, 1991
56. Schmidt EV, Christoph G, Zeller R, Leder P: The cytomegalovirus enhancer a panactive control element in transgenic mice. Mol Cell Biol 10:4406-4411, 1990
57. Morgan DO, Roth RA: Mapping surface structures of the human insulin receptor with monoclonal antibodies: localization of main immunogenic regions to the receptor kinase domain. Biochemistry 25:1364-1371, 1986
58. Zick Y, Grunberger G, Rees-Jones RW, Comi RJ: Use of tyrosine-containing polymers to characterize the substrate specificity of insulin and other hormone-stimulated tyrosine kinases. Euro J Biochem 148:177-182, 1985
59. Kasuga M, Fujita-Yamaguchi Y, Blithe DL, White MF, Kahn CR: Characterization of the insulin receptor kinase purified from human placental membranes. J Biol Chem 258:10973-10980, 1983
60. Stadtmauer LA, Rosen OM: Phosphorylation of exogenous substrates by the insulin receptor-associated protein kinase. J Biol Chem 258:6682-6685, 1983
61. Klein HH, Freidenberg GR, Kladde M, Olefsky JM: Insulin activation of insulin receptor tyrosine kinase in intact rat adipocytes: an in vitro system to measure histone kinase activity of insulin receptors activated in vivo. J Biol Chem 261:4691-4697, 1986
62. Maegawa H, Kobayashi M, Egawa K, McClain DA, Olefsky JM, Shigeta Y: The ligand-binding characteristics of a kinase-defective A/K1018 human insulin receptor expressed in Rat 1 fibroblasts. Biochim Biophys Acta 1053:185-188, 1990
63. Grako KA, McClain DA, Olefsky JM: Hybrid formation between endogenous mouse and transfected human tyrosine kinase-deficient (A/K1018) insulin receptors leads to decreased insulin sensitivity in 3T3-L1 adipocytes. Mol Endocrinol 8:682-692, 1994
64. Chang PY, Goodyear LJ, Benecke H, Markuns JS, Moller DE: Impaired insulin signaling in skeletal muscles from transgenic mice expressing kinase-deficient insulin receptors. J Biol Chem 270:12593-12600, 1995
65. Sanke T, Hanabusa T, Nakano Y, Oki C, Okai K, Nishimura S, Kondo M, Nanjo K: Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 34:129-132, 1991
66. Hoppener JWM, Oosterwijk C, Hulst KL van, Verbeek JS, Capel PJA, de Koning EJP, Clark C, Jansz HS, Lips CJM: Molecular physiology of the islet amyloid polypeptide (iapp)/amylin gene in man, rat, and transgenic mice. J Cell Biochem, 55S:39-53, 1994
67. Wilden PA, Kahn CR: The level of insulin receptor tyrosine kinase activity modulates the activities of phosphatidylinositol 3-kinase, microtubule-associated protein, and S6 kinases. Mol Endocrinol 8:558-567, 1994
68. Frittitta L, Vigneri R, Stampfer MR, Goldfine ID: Insulin receptor overexpression in 184B5 human mammary epithelial cells induces a ligand-dependent transformed phenotype. J Cell Biochem 57:666-669, 1995
69. Levy-Toledano R, Caro LH, Accili D, Taylor SI: Investigation of the mechanism of the dominant negative effect of mutations in the tyrosine kinase domain of the insulin receptor. EMBO J 13:835-842, 1994
70. Hohmeier HE, BeltrandelRio H, Clark SA, Henkel-Rieger R, Normington K, Newgard CB: Regulation of insulin secretion from novel engineered insulinoma cell lines. Diabetes 46:968-977, 1997
71. Bonner-Weir S: Morphological evidence for pancreatic polarity of β-cell within islets of Langerhans. Diabetes 37:616-621, 1988
72. Bruning JC, Winnay J, Bonner-Weir S, Taylor SI, Accili D, Kahn CR: Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88:561-572, 1997
73. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF: Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900-904, 1998
74. Kulkarni RN, Bruning JC, Winnay JN, Magnuson M, Kahn CR: Tissue-specific disruption of the insulin receptor in the pancreatic β-cell results in impaired glucose tolerance (Abstract). Diabetes 47 (Suppl. 1):A57, 1998